Evidence map›Paper›PMID 39858115›Full record

ArticleCancers2025

Correction: Alaei et al. Therapeutic Potential of Targeting the Cytochrome P450 Enzymes Using Lopinavir/Ritonavir in Colorectal Cancer: A Study in Monolayers, Spheroids and In Vivo Models.

Maryam Alaei, Seyedeh Elnaz Nazari, Ghazaleh Pourali, AliReza Asadnia, Mehrdad Moetamani-Ahmadi, Hamid Fiuji, Hamid Tanzadehpanah, Fereshteh Asgharzadeh, Fatemeh Babaei, Fatemeh Khojasteh-Leylakoohi and 8 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Maryam AlaeiDepartment of Clinical Biochemistry, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran.
Seyedeh Elnaz NazariMetabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran.
Ghazaleh PouraliMetabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran.
AliReza AsadniaMetabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran.
Mehrdad Moetamani-AhmadiMetabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran.ORCID 0009-0001-5475-4997
Hamid FiujiBasic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran.
Hamid TanzadehpanahMetabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran.
Fereshteh AsgharzadehMetabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran.ORCID 0000-0002-8349-3722
Fatemeh BabaeiMetabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran.
Fatemeh Khojasteh-LeylakoohiMetabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran.
Ibrahim Saeed GataaCollege of Medicine, University of Warith Al-Anbiyaa, Karbala 56001, Iraq.
Mohammad Ali KianiBasic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran.
Gordon A FernsDepartment of Medical Education, Brighton & Sussex Medical School, Falmer, Brighton, Sussex BN1 9PH, UK.ORCID 0000-0002-0957-8349
Alfred King-Yin LamPathology, School of Medicine and Dentistry, Gold Coast Campus, Griffith University, Gold Coast, QLD 4222, Australia.ORCID 0000-0003-2771-564X
Seyed Mahdi HassanianDepartment of Clinical Biochemistry, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran.
Majid KhazaeiMetabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran.
Elisa GiovannettiDepartment of Medical Oncology, Cancer Center Amsterdam, Amsterdam U.M.C., VU. University Medical Center (VUMC), 1081 HV Amsterdam, The Netherlands.ORCID 0000-0002-7565-7504
Amir AvanMetabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran.ORCID 0000-0002-4968-0962

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39858115
PMCPMC11764396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.